View in EDS

Anti-BCMA CAR T-cell for IgG4-related disease: is this necessary? - Authors' reply.

Saved in:
Bibliographic Details
Title: Anti-BCMA CAR T-cell for IgG4-related disease: is this necessary? - Authors' reply.
Authors: Cai S; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China., Hu Z; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China., Chen Y; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China., Ye C; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China., Zhang J; Shenzhen Pregene Biopharma Company, Shenzhen, China., Sun W; Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Dong L; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: tjhdongll@163.com.
Source: The Lancet. Rheumatology [Lancet Rheumatol] 2026 Apr; Vol. 8 (4), pp. e247-e248. Date of Electronic Publication: 2026 Feb 18.
Publication Type: Letter
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2665-9913 (Electronic) Linking ISSN: 26659913 NLM ISO Abbreviation: Lancet Rheumatol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2665-9913
DOI:10.1016/S2665-9913(26)00040-8